Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers

NCT02202512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: Cimetidine
DRUG: Placebo
DRUG: Placebo
DRUG: BI 1060469 high dose
DRUG: BI 1060469 low dose
DRUG: Naproxen
DRUG: BI 1021958

Sponsor

Boehringer Ingelheim